Gary Hattersley, Chief Scientific Officer at Radius Health, Inc. (RDUS), sold 5,683 shares at $75.00 ($426K) on 2015-11-12, disclosed to the SEC on 2015-11-13.
Scheduled sale ($426k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NUVB | SELL | 2025-10-29 | $1.0M | — | Filing → |
| RDUS | SELL | 2015-11-05 | $933K | — | Filing → |
| RDUS | SELL | 2015-10-27 | $735K | — | Filing → |